Octazamide

• CAT Number: I013373
• CAS Number: 56391-55-0
• Molecular Formula: C₁₃H₁₅NO₂
• Molecular Weight: 217.26
• Purity: ≥95%
• Target: Others
• Solubility: DMSO
• IUPAC Name: 1,3,3a,4,6,6a-hexahydrofuro[3,4-c]pyrrol-5-yl(phenyl)methanone
• InChI: InChI=1S/C13H15NO2/c15-13(10-4-2-1-3-5-10)14-6-11-8-16-9-12(11)7-14/h1-5,11-12H,6-9H2
• InChIKey: ZSYULWHBPBAOKV-UHFFFAOYSA-N
• SMILES: C1C2COCC2CN1C(=O)C3=CC=CC=C3

Octazamide(CAT: I013373) is a sulfonylurea derivative primarily studied for its hypoglycemic properties. It functions by stimulating insulin release from pancreatic β-cells through inhibition of ATP-sensitive potassium (K ATP) channels. This mechanism depolarizes the cell membrane, triggering calcium influx and subsequent insulin secretion. Octazamide is significant in diabetes research, particularly in exploring the regulation of glucose homeostasis and the pharmacological modulation of insulin release. Its specificity and efficacy make it a valuable tool for studying sulfonylurea receptor interactions and advancing therapeutic strategies for type 2 diabetes management.